PCN116 COST-EFFECTIVENESS OF PEMBROLIZUMAB (KEYTRUDA®) PLUS PLATINUM-PEMETREXED FOR FIRST-LINE TREATMENT OF METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER IN FRANCE
Abstract
Authors
C. Chouaid L. Bensimon A. Millier E. Clay R. Insinga A. Arunachalam A. Khandelwal L. Levy Bachelot P. Levy